Form 4: Rocket Pharmaceuticals Executive Sells Shares
Insider Transaction (Form 4)
Martin Wilson, General Counsel of Rocket Pharmaceuticals, Inc., sold 75,364 shares of common stock on September 11, 2026 for $3.40 per share.
Summary
- Open-market sale: disposed of 75,364 Common Stock at $3.40 ($256,464) on September 11, 2026; holds 598,489 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $256,464 of stock on the open market.
Insider Transactions
Martin Wilson — Officer (General Counsel)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-11 | Open-market sale | Common Stock | 75,364 | $3 | $256.5K | 598,489 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-11 | Open-market sale (75,364 shares) |
Keywords
insider transaction, Form 4, RCKT, ROCKET PHARMACEUTICALS, INC., bearish, Martin Wilson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.